Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers

Ads

You May Also Like

VitalHub Announces Sale of B Care to support Osler’s Cardiac Care Program

TORONTO, July 31, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) ...

Athenex Announces Recent Product Launches in 503B and Specialty Injectables Business Units

BUFFALO, N.Y., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical ...